Air pollutant levels positively correlate with increases in both acute and chronic cardiovascular disease. The pollutant diesel exhaust (DE) increases endothelin (ET) levels, suggesting that this peptide may contribute to DE-induced cardiovascular disease. We hypothesized that acute exposure to DE also enhances ET-1-mediated coronary artery constrictor sensitivity. Constrictor responses to KCl, U-46619, and ET-1 were recorded by videomicroscopy in pressurized intraseptal coronary arteries from rats exposed for 5 h to DE (300 g/m 3 ) or filtered air (Air). ET-1 constriction was augmented in arteries from DE-exposed rats. Nitric oxide synthase (NOS) inhibition [N -nitro-Larginine (L-NNA), 100 M] and endothelium inactivation augmented ET-1 responses in arteries from Air but not DE rats so that after either treatment responses were not different between groups. DE exposure did not affect KCl and U-46619 constrictor responses, while NOS inhibition augmented KCl constriction equally in both groups. Thus basal NOS activity does not appear to be affected by DE exposure. The endothelin type B (ET B) receptor antagonist BQ-788 (10 M) inhibited ET-1 constriction in DE but not Air arteries, and constriction in the presence of the antagonist was not different between groups. Cytokine levels were not different in plasma from DE and AIR rats, suggesting that acute exposure to DE does not cause an immediate inflammatory response. In summary, a 5-h DE exposure selectively increases constrictor sensitivity to ET-1. This augmentation is endothelium-, NOS-, and ET B receptor dependent. These data suggest that DE exposure diminishes ET B receptor activation of endothelial NOS and augments ET B-dependent vasoconstriction. This augmented coronary vasoreactivity to ET-1 after DE, coupled with previous reports that DE induces production of ET-1, suggests that ET-1 may contribute to the increased incidence of cardiac events during acute increases in air pollution levels. nitric oxide synthase; exhaust; N -nitro-L-arginine; arteries; rat EPIDEMIOLOGIC STUDIES have linked air pollution to an increased incidence of cardiovascular morbidity and mortality (23, 37, 38, 43, 47 The worldwide use of diesel engines in road and nonroad machinery and in passenger vehicles contributes substantially to ambient air pollution and, potentially, to associated health problems. Indeed, previous studies have shown that inhaled diesel exhaust (DE) adversely affects cardiovascular parameters (31, 35, 44), but little is known about the mechanism underlying these effects. DE is a complex mixture of particulate and gaseous phases, both of which exert unique adverse health effects. Diesel engines emit 30 -100 times more particulates than gasoline engines (45), and the U.S. Environmental Protection Agency (EPA) estimates that ϳ20% of the particulates in urban air in the U.S. mid-Atlantic region originates from DE (46). This particulate phase has been associated with direct vasoconstrictor effects (27), exacerbation of atherosclerosis (2), and inhibition of endothelial function (16, 41) . In addition, DE contains gaseous compounds including nitrogen oxides (NO x ), CO, and volatile organics that are also associated with arrhythmias and adverse cardiac events (9, 36, 39) .
The worldwide use of diesel engines in road and nonroad machinery and in passenger vehicles contributes substantially to ambient air pollution and, potentially, to associated health problems. Indeed, previous studies have shown that inhaled diesel exhaust (DE) adversely affects cardiovascular parameters (31, 35, 44) , but little is known about the mechanism underlying these effects. DE is a complex mixture of particulate and gaseous phases, both of which exert unique adverse health effects. Diesel engines emit 30 -100 times more particulates than gasoline engines (45) , and the U.S. Environmental Protection Agency (EPA) estimates that ϳ20% of the particulates in urban air in the U.S. mid-Atlantic region originates from DE (46) . This particulate phase has been associated with direct vasoconstrictor effects (27) , exacerbation of atherosclerosis (2) , and inhibition of endothelial function (16, 41) . In addition, DE contains gaseous compounds including nitrogen oxides (NO x ), CO, and volatile organics that are also associated with arrhythmias and adverse cardiac events (9, 36, 39) .
Metabolic changes associated with DE exposure include increased plasma endothelin (ET) (28, 35) , which has been associated with many cardiovascular disease states including heart failure and left ventricular hypertrophy (3, 21) . In human heart and coronary arteries, endothelin type A receptor (ET A R) is the predominant ET receptor (8, 20, 33) and its activation by ET potently stimulates both cardiac hypertrophy and vasoconstriction (26, 29) . Compared with healthy individuals, hypertensive patients (15) and coronary bypass patients (26) have increased ET A R-mediated vasoconstrictor tone. Although smooth muscle cell endothelin type B receptors (ET B Rs) can contribute to vasoconstriction in some vascular beds (17, 24) , their primary contribution to vascular tone in the coronary circulation is not well characterized. In contrast, endothelial ET B Rs have beneficial effects on the vascular wall by clearing ET from plasma and by stimulating generation of the vasodilator nitric oxide (NO) (18, 22) . Thus elevated receptor expression and/or function could predispose individuals to the negative cardiovascular sequelae of DE, which appears to activate the ET constrictor pathway (28) .
We showed previously (7) that DE-exposed rats maintained a higher heart rate and displayed markers of ventricular arrhythmias. Furthermore, exposure of isolated murine coronary arteries to diesel emissions augments vasoconstriction (6); however, the effect of inhaled diesel emissions and the underlying biological mechanisms for such effects remain unknown. Thus the present study exposed healthy rats to inhaled DE to test the hypothesis that DE acutely augments coronary artery vasoreactivity via ET receptor-mediated pathways.
METHODS

Animals.
All animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the Lovelace Respiratory Research Institute (LRRI) and conform to National Institutes of Health (NIH) guidelines for animal use. Male Sprague-Dawley rats (250 -300 g, Charles River Laboratories) were exposed to 300 g particulate matter (PM)/m 3 DE in a sealed chamber for 5 h. This exposure is approximately equal to the 24-h limit for PM set by the EPA for humans. The DE system has been previously characterized and produces levels of CO and NOx at ϳ3 ppm and 4 ppm, respectively (30) . Control (Air) rats were housed identically but exposed to filtered air. Within chambers, rats were housed in standard cages and maintained on a 12:12-h light-dark cycle with food and water available ad libitum before exposures. Food was withdrawn during DE exposure.
DE exposure. DE was generated from a single-cylinder, 5,500-W Yanmar diesel generator using nationally certified diesel fuel at the LRRI facility. Electrical current was drained from the engine to provide a constant 90% load during operation to ensure consistent emissions. The particle concentration was monitored by sampling on 47-mm Pallflex (Pall-Gelman) filters. Filters were collected two times a day (every 3 h) from each DE exposure chamber and once per day from the control chamber. Prefilter and postfilter weights were measured with a microbalance, and desired concentrations of the emissions were attained by diluting the direct exhaust with filtered air. Exposure chamber temperature and humidity were monitored throughout exposures, and temperatures were maintained at 20 -25°C (30) .
Isolated artery preparation. At the end of the 5-h exposure, fumes were off-gassed for 30 min and then the rats were euthanized with pentobarbital sodium (200 mg/kg ip). Hearts were immediately removed, and intraseptal coronary arteries with an inner diameters of equivalent size between groups (Air: 184 Ϯ 8 m, DE: 187 Ϯ 8 m) were isolated and placed in chilled physiological saline solution (PSS; in mM: 129.8 NaCl, 5.4 KCl, 0.83 MgSO4, 19 NaHCO3, 1.8 CaCl2, and 5.5 glucose) aerated with 21% O 2-6% CO2-73% N2. Each artery was used for only one experimental treatment. Both ends of the arteries were cannulated onto glass micropipettes in a tissue chamber (Living Systems, CH-1) and secured with silk sutures within 30 min of isolation from the heart. Vessels were stretched to approximate in situ length and pressurized to 60 mmHg with PSS in the lumen absent of flow and superfused at a rate of 5 ml/min with 37°C oxygenated PSS. At the end of the experiment, Ca 2ϩ -free PSS was superfused for 60 min to fully relax the vessel. The endothelium was disrupted in some experiments by rubbing the lumen of the artery with a strand of moose mane inserted into the free distal end of a vessel attached at the proximal end to a cannula. Loose endothelial cells were then flushed from the artery before the distal end was cannulated and secured with silk sutures. Endothelial inactivation was verified by the lack of a dilator response to ACh and a maintained constrictor response to U-46619 (5) .
Contractile studies. Vessel chambers were placed on the stage of an inverted Nikon Eclipse TS 100 microscope fitted with a video camera connected to a data acquisition computer. Inner diameter changes were recorded with edge detection software (IonOptix) as described previously (10) . Arteries were treated for at least 30 min with nitric oxide synthase (NOS) inhibitor N -nitro-L-arginine (L-NNA, 100 M), ET BR antagonist BQ-788 (10 M), ETAR antagonist BQ-123 (10 M), or vehicle in the superfusate and in the lumen before constriction with increasing concentrations of ET-1 (0.1-10 nM), KCl (10 -90 mM), or thromboxane A2 mimetic U-46619 (0.1 nM-1 mM) added to the recirculating superfusate.
Quantitative PCR. Total RNA was extracted from coronary arteries with the RNeasy Fibrous Tissue Mini Kit (Qiagen). Reverse transcription-generated cDNA (High Capacity cDNA Reverse Transcription Kit, Applied Biosystems) and real-time PCR for ETAR, ETBR, and the endogenous control 18S were performed with an Applied Biosystems Fast 7500 PCR machine and TaqMan Gene Expression Assays. Data are expressed as relative change from the Air group.
Plasma NO x, ET-1, and inflammatory response. Blood was collected via cardiac puncture from anesthetized rats, chilled on ice, and centrifuged at 1,000 rpm within 15 min of collection. Aliquots of plasma were frozen in liquid nitrogen and stored at Ϫ80°C. NO released from the endothelium is rapidly oxidized to nitrite (NO 2 Ϫ ) and nitrate (NO 3 Ϫ ), so that a change in plasma NOx (sum of NO 2 Ϫ and NO 3 Ϫ ) is a crude measure of NO release. Total NOx levels were assayed with a nitrate/nitrite colorimetric assay (Cayman Chemical) based on the Griess assay. Circulating plasma ET-1 peptide was assayed by chemiluminescent immunoassay (R&D Systems). Plasma levels of granulocyte colony-stimulating factor (G-CSF), macrophage inflammatory protein 1␣ (MIP-1␣), interleukin-1 (IL-1)␤, IL-4, IL-2, IL-6, tumor necrosis factor (TNF)-␣, monocyte chemotactic protein 1 (MCP-1), interferon (IFN)-␥, and growth-related oncogene (GRO-KC) were used as markers of inflammation and assayed with Milliplex MAP rat cytokine immunoassay (Millipore).
Statistical analysis and calculations. Constrictor responses were analyzed by two-way repeated-measures ANOVA with Student-Newman-Keuls post hoc analysis for differences between groups, concentrations, and interactions. Differences in ET receptor mRNA, plasma NO x, and ET-1 between groups were analyzed by Student's t-test. P Ͻ 0.05 was considered statistically significant for all analyses. Active tone (myogenic or drug induced) is calculated as the percent change in inner diameter:
RESULTS
DE augments endothelium-dependent ET-1 constriction.
Coronary arteries from rats exposed to DE had enhanced vasoconstrictor responses to ET-1 compared with arteries from Air-exposed rats (Fig. 1A , P Ͻ 0.001). Maximal constriction was greater in the DE group compared with the Air group (80 Ϯ 7% vs. 49 Ϯ 7%, P Ͻ 0.001). The inner diameter of fully relaxed (Ca 2ϩ -free PSS) coronary arteries was not different between Air-and DE-exposed animals (167 Ϯ 9 vs. 191 Ϯ 21 m, respectively). ET-1 vasoconstriction was augmented only in the Air group by inactivation of the endothelium, and the response was not different between groups in endotheliumdisrupted arteries (Fig. 1B) . Maximal constriction after endothelial inactivation was 74 Ϯ 4% versus 72 Ϯ 5% in Air and DE arteries, respectively (P ϭ 0.687).
KCl-mediated constriction unchanged after DE. Receptorindependent vasoconstriction was assessed by increasing extracellular KCl (10 -90 mM). Constrictor responses in endothelium-intact arteries from Air-and DE-exposed rats were similar ( Fig. 2A) . Removal of the endothelium augmented KCl-mediated constriction in both groups, and responses were still not different between groups (Fig. 2, B and C) . Coronary arteries from Air-and DE-exposed rats displayed myogenic tone that was not different between groups (17 Ϯ 4% and 20 Ϯ 5%, respectively) and was abolished with endothelium removal (Fig. 2) . In endothelium-intact arteries, low concentrations of KCl (Ͻ30 mM) maximally dilated arteries from both groups, and arterial diameter in Ca 2ϩ -free PSS was not different between Air-and DE-exposed groups (192 Ϯ 9 vs. 188 Ϯ 9 m, respectively).
Enhanced ET-1 vasoconstriction is NOS dependent. NOS inhibition with L-NNA (100 M) augmented constrictor sensitivity to ET-1 in the Air group (Fig. 3A) compared with vehicle. In contrast, NOS inhibition diminished ET-1 constriction in the DE-exposed group at low concentrations without affecting the maximum constriction (Fig. 3B) . L-NNA treatment augmented the KCl response in both groups so that, as in the untreated arteries, KCl-induced constriction was not different between groups in the presence of the NOS inhibitor (Fig. 4) .
ET B R mediates augmented ET-1 constriction after DE. BQ-788 did not alter ET-1-mediated vasoconstriction in the Air group (Fig. 5A) . However, ET B R antagonism with BQ-788 diminished ET-1-mediated vasoconstriction in coronary arteries from DE-exposed rats (Fig. 5B) , normalizing constrictor responses to those in the Air group. In the absence of a functional endothelium, BQ-788 slightly diminished ET-1-mediated constriction in both groups (Fig. 6) . The majority of ET-1-mediated vasoconstriction was prevented after ET A R blockade with BQ-123 in endothelium-intact coronary arteries from both groups. Arteries from DE-exposed animals still displayed a small constrictor response to 10 nM ET-1 in the presence of ET A R blockade (Fig. 7) . Constriction to the thromboxane A 2 mimetic U-46619 (0.1 nM-1 mM) was not different between groups (data not shown, P ϭ 0.87).
ET-1 and its receptors not altered by DE. Changes in Air and DE coronary artery expression of ET A R (1.01 Ϯ 0.07 vs.
1.08 Ϯ 0.09 fold change from control, P ϭ 0.77) and ET B R (1.08 Ϯ 0.20 vs. 0.97 Ϯ 0.20 fold change from control, P ϭ 0.68) were evaluated by quantitative real-time PCR, and no differences in transcript levels between groups were found. Circulating ET-1 was also not different between groups (Fig. 8A) .
Plasma NO x elevated after exposure. After a 5-h exposure to DE (Fig. 8B) , plasma levels of NO x (9.5 Ϯ 0.5 M) were elevated almost twofold compared with NO x levels in animals exposed to air (4.0 Ϯ 0.5 M, P Ͻ 0.05).
Inflammatory cytokine levels. Plasma levels of MCP-1, IL-4, IL-2, IL-6, IFN-␥, and GRO-KC were not different between Air and DE rats, while G-CSF, MIP-1␣, IL-1␤, and TNF-␣ were below detection limits (data not shown, n ϭ 4 or 5/group).
DISCUSSION
The major finding in this study is that inhaled DE caused a dramatic increase in constrictor responses to ET-1 in endothelium-intact coronary arteries. The enhanced response was only seen in arteries when the endothelium was intact, NOS was not inhibited, and ET B R were not blocked. Furthermore, DE exposure did not affect constrictor responses to KCl-induced depolarization or to the thromboxane A 2 mimetic U-46619. Therefore it appears that DE inhalation suppresses the generation of an endothelial vasodilator that opposes ET-1 constriction. Because inhibiting NOS and removing the endothelium similarly augmented ET-1-mediated constriction in arteries from Air animals but did not affect ET-1-mediated constriction in arteries from DE-exposed animals, it appears that the lost vasodilator opposing ET-1 constriction is endothelial NO. Although NOS inhibition did not augment responses to ET-1 in arteries from DE-exposed animals, it did have the unexpected affect of diminishing ET-1-mediated constriction at low concentrations, implying that ET-1 causes a NOS-dependent constriction (Fig. 3B) . Thus acute DE exposure appears to augment ET-1 constriction by reducing bioavailable NO and also by generating an endothelium-derived NOS-dependent constrictor.
On the other hand, NOS inhibition might have reduced ET-1-dependent constriction in the DE arteries by enhancing the production of a cyclooxygenase (COX)-derived vasodilator such as PGI 2 . NO has been shown to inhibit PGI 2 production by decreasing Ca 2ϩ entry (42) . Therefore increased NO production after DE exposure may have inhibited PGI 2 to cause the elevated ET-1 constriction in the untreated arteries. Inhibition of endothelial NOS (eNOS) would restore PGI 2 synthesis, leading to the observed diminished constriction in the presence of the NOS inhibitor. However, if NO-induced COX inhibition was the cause of the augmented constriction, then inhibiting NOS should also have reduced constriction to KCl. This was not observed. In fact, NOS inhibition increased KCl-induced constriction. Furthermore, blocking ET B R or removing the endothelium also should not have diminished the constriction unless these were a source of the constrictor. Therefore the loss of a COX-derived vasodilator after DE exposure does not appear likely but can only be truly defined by further investigation into this pathway.
An alternative possibility is that eNOS is actually the direct cause of the augmented constriction. NOS-derived vasoconstrictors can be generated when the enzyme is uncoupled. Usually, the heme-containing homodimer eNOS generates NO (1, 12, 34) . However, components of DE can generate reactive oxygen species (ROS) (4, 14) that react with NO to form peroxynitrite and diminish NO bioavailability. ROS, including peroxynitrite, oxidize the requisite NOS cofactor tetrahydrobiopterin (BH 4 ), leading to NOS uncoupling (12) . The superoxide generated by uncoupled NOS can further augment tone both by exacerbating NOS uncoupling and by directly mediating vasoconstriction (40, 48) . Therefore, DE-generated ROS could lead to NOS uncoupling, depleting bioavailable NO and generating a NOS-dependent constriction.
Unlike ET-1-stimulated NOS activation, basal NO production does not appear to be different between groups. This is concluded from the observation that constrictor responses to KCl were the same in endothelium-intact coronary arteries from Air-and DE-exposed animals and NOS inhibition similarly augmented KCl constriction in both groups (Fig. 2A) . The enhanced KCl-induced constriction following NOS inhibition indicates that basal NO diminishes vascular tone. However, ET-1-stimulated NOS activation appears to be disrupted in the coronary arteries from DE-exposed rats. That is, ET-1 activates ET B R on both vascular endothelial and smooth muscle cells (22) to elicit smooth muscle-dependent constriction and endothelium-dependent dilation (18, 22) . The final level of tone is the sum of these two responses. With KCl-induced depolarization and thromboxane receptor activation, the response is primarily mediated by activation of smooth muscle pathways that are modulated by basal rather than stimulated endothelial dilators. Thus the selective augmentation of ET-1 constriction that is prevented by removing the endothelium, blocking ET B R, or inhibiting NOS suggests that DE affects ET-1-stimulated endothelial NOS but not basal activity of the enzyme. , while activation of a heterodimer causes a sustained intracellular Ca 2ϩ elevation (11) . Therefore increased heterodimer expression would lead to increased vasoconstriction. However, selective inhibition of either ET A R or ET B R alone does not affect heterodimerization and does not diminish the ability of heterodimer pairs to mobilize Ca 2ϩ (11, 13) . Therefore in the presence of heterodimerization, both receptors must be blocked to prevent ET-1-induced constriction. Because either ET A R or ET B R blockade alone diminished constriction in both Air and DE endothelium-denuded arteries, this suggests the that smooth muscle effect is not through a heterodimer effect. Furthermore, the effect of ET B R blockade was much greater in the endothelium-intact DE arteries, further supporting an endothelial ET B R-mediated dysfunction.
A lack of effect of DE on basal NOS activity is also suggested by the observation that there is an increase rather than a decrease in circulating NO x . Although the origin of the plasma NO x was not determined, elevated plasma NO x is likely due to the high level of NO in DE (30) . It is intriguing to speculate that this elevated exogenous NO might be the factor that uncouples endogenous NOS to contribute to the impaired NO generation. Previous studies have suggested that exposure to high levels of NO can indeed nitrosylate eNOS (32) , but future studies with DE and NO will be needed to directly address this possibility.
The role of ET B R in the activation of the NOS pathway was evaluated with the selective receptor antagonist BQ-788. In endothelium-disrupted arteries, BQ-788 had a modest effect in diminishing the ET-1 constriction in both groups (Fig. 6) , indicating a small contribution of smooth muscle ET B R to the ET-1 response. BQ-788 did not affect ET-1-mediated constriction in endothelium-intact coronary arteries from the Air group (Fig. 5A) , suggesting that the combined blockade of endothelial ET B R-mediated dilation and smooth muscle ET B R-mediated constriction may cancel each other out, leading to no observed effect in endothelium-intact arteries. Supporting this possibility is the observation that ET-1-mediated constriction in endothelium-intact arteries from the Air group is abolished in the presence of the ET A R antagonist BQ-123 (Fig. 7) , such that opposing actions of activated endothelial and smooth muscle ET B R would be seen as no ET-1 constrictor response. In contrast, ET B R blockade diminished vasoconstriction (Fig.  5B) , and a modest ET B R-dependent constriction remained after ET A R antagonism (Fig. 7) in endothelium-intact arteries from DE-exposed animals. Therefore DE exposure appears to impair ET B R-mediated dilator function so that only a constrictor effect remains. Furthermore, at low ET-1 concentrations, BQ-788 and L-NNA both diminished constriction in endotheliumintact arteries, suggesting that endothelial ET B Rs stimulate NOS to produce vasoconstrictors in the DE arteries. In endothelium-disrupted arteries, very high concentrations of ET-1 were required to activate smooth muscle ET B Rs and mediate constriction directly. Therefore, the overall effect of BQ-788 in endothelium-intact arteries from DE-exposed animals is to normalize constriction to that of the Air arteries.
The observed alteration in coronary artery vascular function does not appear to be mediated by an inflammatory response to DE. Plasma levels of cytokines shown to be activated in acute inflammation were not different between groups after exposure. This is in agreement with previous observations that exposure to similar levels of whole DE alter vasoconstriction of mesenteric veins in the absence of inflammation (25) . Additionally, exposure to DE-bubbled PSS enhanced ET-1-mediated constriction in coronary arteries (6) and mesenteric veins (25) similarly to the effects of whole body exposure. These observations support a direct effect of component(s) of DE to alter vascular function.
Perspectives and Significance
Enhanced vasoconstriction after DE exposure has been previously reported in other animal models and in human studies.
In apolipoprotein E (apoE)-knockout mice, DE inhalation enhanced coronary artery constriction to ET-1 and depressed T waves, indicating myocardial ischemia (6) . Similarly, DE exposure during stress testing in patients with prior myocardial ischemia elicited dramatic changes in ST segment voltage compared with control subjects (31) . Other systemic targets of DE include the mesenteric circulation, where enhanced constriction was normalized with NOS inhibition, suggesting that NOS is uncoupled in this bed as well (25) . In human volunteers exposed to inhaled DE, brachial artery diameter decreased and plasma ET-1 increased (35) . Thus DE effects on the endothelium may augment coronary constriction to the endogenous vasoconstrictor ET-1 to decrease blood flow to the heart, contributing to cardiac events seen epidemiologically. These However, the NOx concentration in plasma from DE-exposed animals was almost double that of plasma from the Air rats (*P Ͻ 0.05). n ϭ 4 or 5 per group.
negative effects of DE can be persistent and long-standing (44) , possibly contributing to the biphasic cardiovascular effects of elevated pollution levels.
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